Skip to content

Comment on Ask HN Hackers: What's R's future?

Comments

It is still going strong in bioinformatics/genomics. I think it's slower and clunkier than the alternatives, but for stats and graphics it's pretty easy for scientists to learn...

It's also slowly getting a foot hold in Pharma. I think the large Pharma companies would love to get out from under the expensive SAS licenses.

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.